4.91 -0.28 (-5.4%) | 04-29 16:00 | |||||||||||||
|
|
Short term | ||||
Mid term | ||||
Targets | 6-month : | 6.86 | 1-year : | 8.4 |
Resists | First : | 5.87 | Second : | 7.19 |
Pivot price | 5.48 | |||
Supports | First : | 3.73 | Second : | 3.1 |
MAs | MA(5) : | 5.05 | MA(20) : | 5.53 |
MA(100) : | 3.31 | MA(250) : | 5.93 | |
MACD | MACD : | 0 | Signal : | 0.1 |
%K %D | K(14,3) : | 14.3 | D(3) : | 15.5 |
RSI | RSI(14): 47.4 | |||
52-week | High : | 11.72 | Low : | 0.74 |
Price has closed below its short-term moving average. Short-term moving average is currently below mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is BEARISH in short-term; and NEUTRAL in mid-long term.[ COCH ] has closed above bottom band by 25.1%. Bollinger Bands are 30.2% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.
If tomorrow: | Open lower | Open higher |
High: | 5.27 - 5.29 | 5.29 - 5.32 |
Low: | 4.85 - 4.88 | 4.88 - 4.9 |
Close: | 4.86 - 4.91 | 4.91 - 4.95 |
Envoy Medical, Inc., a hearing health company, provides medical technologies for the hearing loss spectrum. Its products include hearing aids; Esteem middle ear implants; bone conduction devices; and Acclaim cochlear implants. Envoy Medical Corporation was formerly known as St. Croix Medical, Inc. and changed its name to Envoy Medical Corporation in December 2004. The company was founded in 1995 and is based in White Bear Lake, Minnesota.
Sat, 20 Apr 2024
ROSEN, A LONGSTANDING LAW FIRM, Encourages Envoy Medical, Inc. Investors to Inquire About Securities Class ... - PR Newswire
Mon, 04 Mar 2024
Envoy Medical Secures $10M to Advance Fully Implanted Cochlear Implant - HIT Consultant
Sun, 03 Mar 2024
Insiders with their considerable ownership were the key benefactors as Envoy Medical, Inc. (NASDAQ:COCH) touches ... - Yahoo Finance
Thu, 29 Feb 2024
Why Okta Shares Are Trading Higher By Around 24%; Here Are 20 Stocks Moving Premarket - Markets Insider
Mon, 22 Jan 2024
MCRA Provides Anzu Special Acquisition Corp I with Strategic Diligence Support Leading to Envoy Medical Merger ... - PR Newswire
Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Underperform |
Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Underperform |
Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Neutral |
Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Underperform |
Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Outperform |
Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Underperform |
Exchange:
NASDAQ
|
|
Sector:
Healthcare
|
|
Industry:
Medical - Devices
|
|
Shares Out | 0 (M) |
Shares Float | 20 (M) |
Held by Insiders | 7.16e+006 (%) |
Held by Institutions | 63.6 (%) |
Shares Short | 11 (K) |
Shares Short P.Month | 0 (K) |
EPS | -1.824e+007 |
EPS Est Next Qtrly | 0 |
EPS Est This Year | 0 |
EPS Est Next Year | 0 |
Book Value (p.s.) | 0 |
Profit Margin | 0 % |
Operating Margin | -7 % |
Return on Assets (ttm) | 89.4 % |
Return on Equity (ttm) | -225.3 % |
Qtrly Rev. Growth | 316000 % |
Gross Profit (p.s.) | 140.97 |
Sales Per Share | 0 |
EBITDA (p.s.) | 0 |
Qtrly Earnings Growth | -2.4 % |
Operating Cash Flow | 0 (M) |
Levered Free Cash Flow | -18 (M) |
PE Ratio | -0.01 |
PEG Ratio | 0 |
Price to Book value | 0 |
Price to Sales | 0 |
Price to Cash Flow | -145.12 |
Dividend | 0 |
Forward Dividend | 42530 |
Dividend Yield | 0% |
Dividend Pay Date | Invalid DateTime. |
Ex-Dividend Date | Invalid DateTime. |